COVID-19 Impact on Global Pharmacogenomics (PGx) Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Polymerase Chain Reaction (PCR)
  • 1.4.3 Microarray
  • 1.4.4 Sequencing
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Pharmacogenomics (PGx) Market Share by Application: 2020 VS 2026
  • 1.5.2 Cardiovascular Diseases (CVD)
  • 1.5.3 Central Nervous System (CNS)
  • 1.5.4 Cancer/Oncology
  • 1.5.5 Infectious Diseases
  • 1.5.6 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Pharmacogenomics (PGx) Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Pharmacogenomics (PGx) Industry
    • 1.6.1.1 Pharmacogenomics (PGx) Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Pharmacogenomics (PGx) Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Pharmacogenomics (PGx) Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Pharmacogenomics (PGx) Market Perspective (2015-2026)
• 2.2 Pharmacogenomics (PGx) Growth Trends by Regions
  • 2.2.1 Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmacogenomics (PGx) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmacogenomics (PGx) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmacogenomics (PGx) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmacogenomics (PGx) Players by Market Size
  • 3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmacogenomics (PGx) Market Concentration Ratio
  • 3.2.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2019
• 3.3 Pharmacogenomics (PGx) Key Players Head office and Area Served
• 3.4 Key Players Pharmacogenomics (PGx) Product Solution and Service
• 3.5 Date of Enter into Pharmacogenomics (PGx) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2021-2026)

5 Pharmacogenomics (PGx) Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmacogenomics (PGx) Market Size by Application (2015-2020)
• 5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmacogenomics (PGx) Market Size (2015-2020)
• 6.2 Pharmacogenomics (PGx) Key Players in North America (2019-2020)
• 6.3 North America Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 6.4 North America Pharmacogenomics (PGx) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmacogenomics (PGx) Market Size (2015-2020)
• 7.2 Pharmacogenomics (PGx) Key Players in Europe (2019-2020)
• 7.3 Europe Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 7.4 Europe Pharmacogenomics (PGx) Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmacogenomics (PGx) Market Size (2015-2020)
• 8.2 Pharmacogenomics (PGx) Key Players in China (2019-2020)
• 8.3 China Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 8.4 China Pharmacogenomics (PGx) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmacogenomics (PGx) Market Size (2015-2020)
• 9.2 Pharmacogenomics (PGx) Key Players in Japan (2019-2020)
• 9.3 Japan Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 9.4 Japan Pharmacogenomics (PGx) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmacogenomics (PGx) Market Size (2015-2020)
• 10.2 Pharmacogenomics (PGx) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmacogenomics (PGx) Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmacogenomics (PGx) Market Size (2015-2020)
• 11.2 Pharmacogenomics (PGx) Key Players in India (2019-2020)
• 11.3 India Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 11.4 India Pharmacogenomics (PGx) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmacogenomics (PGx) Market Size (2015-2020)
• 12.2 Pharmacogenomics (PGx) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmacogenomics (PGx) Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmacogenomics (PGx) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Laboratories
  • 13.1.1 Abbott Laboratories Company Details
  • 13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction
  • 13.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2015-2020))
  • 13.1.5 Abbott Laboratories Recent Development
• 13.2 Affymetrix, Inc.
  • 13.2.1 Affymetrix, Inc. Company Details
  • 13.2.2 Affymetrix, Inc. Business Overview and Its Total Revenue
  • 13.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction
  • 13.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.2.5 Affymetrix, Inc. Recent Development
• 13.3 Assurex Health, Inc
  • 13.3.1 Assurex Health, Inc Company Details
  • 13.3.2 Assurex Health, Inc Business Overview and Its Total Revenue
  • 13.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction
  • 13.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.3.5 Assurex Health, Inc Recent Development
• 13.4 Astrazeneca
  • 13.4.1 Astrazeneca Company Details
  • 13.4.2 Astrazeneca Business Overview and Its Total Revenue
  • 13.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction
  • 13.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.4.5 Astrazeneca Recent Development
• 13.5 GeneDX
  • 13.5.1 GeneDX Company Details
  • 13.5.2 GeneDX Business Overview and Its Total Revenue
  • 13.5.3 GeneDX Pharmacogenomics (PGx) Introduction
  • 13.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.5.5 GeneDX Recent Development
• 13.6 Illumina, Inc.
  • 13.6.1 Illumina, Inc. Company Details
  • 13.6.2 Illumina, Inc. Business Overview and Its Total Revenue
  • 13.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction
  • 13.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.6.5 Illumina, Inc. Recent Development
• 13.7 Laboratory Corporation of America Holdings
  • 13.7.1 Laboratory Corporation of America Holdings Company Details
  • 13.7.2 Laboratory Corporation of America Holdings Business Overview and Its Total Revenue
  • 13.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction
  • 13.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.7.5 Laboratory Corporation of America Holdings Recent Development
• 13.8 Myriad Genetics, Inc.
  • 13.8.1 Myriad Genetics, Inc. Company Details
  • 13.8.2 Myriad Genetics, Inc. Business Overview and Its Total Revenue
  • 13.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction
  • 13.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.8.5 Myriad Genetics, Inc. Recent Development
• 13.9 Pathway Genomics
  • 13.9.1 Pathway Genomics Company Details
  • 13.9.2 Pathway Genomics Business Overview and Its Total Revenue
  • 13.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction
  • 13.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.9.5 Pathway Genomics Recent Development
• 13.10 Pfizer, Inc
  • 13.10.1 Pfizer, Inc Company Details
  • 13.10.2 Pfizer, Inc Business Overview and Its Total Revenue
  • 13.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction
  • 13.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 13.10.5 Pfizer, Inc Recent Development
• 13.11 Qiagen, Inc.
  • 10.11.1 Qiagen, Inc. Company Details
  • 10.11.2 Qiagen, Inc. Business Overview and Its Total Revenue
  • 10.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction
  • 10.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 10.11.5 Qiagen, Inc. Recent Development
• 13.12 Rocheg
  • 10.12.1 Rocheg Company Details
  • 10.12.2 Rocheg Business Overview and Its Total Revenue
  • 10.12.3 Rocheg Pharmacogenomics (PGx) Introduction
  • 10.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 10.12.5 Rocheg Recent Development
• 13.13 Teva Pharmaceutical Industries Ltd.
  • 10.13.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 10.13.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
  • 10.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction
  • 10.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 10.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
• 13.14 Thermo Fisher Scientific
  • 10.14.1 Thermo Fisher Scientific Company Details
  • 10.14.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 10.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction
  • 10.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 10.14.5 Thermo Fisher Scientific Recent Development
• 13.15 Transgenomic, Inc.
  • 10.15.1 Transgenomic, Inc. Company Details
  • 10.15.2 Transgenomic, Inc. Business Overview and Its Total Revenue
  • 10.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction
  • 10.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2015-2020)
  • 10.15.5 Transgenomic, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer